JPMORGAN CHASE & CO - ADAMIS PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$0392
-2.5%
0.00%
Q4 2022$0402
-28.2%
0.00%
Q3 2022$0
-100.0%
560
-98.1%
0.00%
Q2 2022$14,000
-70.8%
28,800
-66.0%
0.00%
Q1 2022$48,000
-63.6%
84,775
-61.2%
0.00%
Q4 2021$132,000
+428.0%
218,573
+735.2%
0.00%
Q3 2021$25,000
-46.8%
26,170
-39.0%
0.00%
Q2 2021$47,000
+327.3%
42,900
+261.6%
0.00%
Q1 2021$11,00011,864
+169385.7%
0.00%
Q4 2020$0
-100.0%
7
-100.0%
0.00%
Q3 2020$13,00016,7000.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders